Richfox Capital Investment Management AG

Richfox Capital Investment Management AG is a Switzerland-based investment manager whose public footprint suggests a private investment shop focused on growth-stage and later opportunities, including healthcare and life sciences exposure as part of a broader thematic mandate. Public data on stage, check size, and AI specificity is thin, so founders should treat this as a generalist sophisticated capital provider rather than a healthcare-AI specialist. The natural profile that fits is a revenue-generating company with a clear path to profitability, where the firm can underwrite a growth round or a late private financing rather than a high-risk seed bet. Healthcare founders should approach only if they have meaningful commercial traction, ideally European reference customers or a credible plan to expand across the continent. Pre-revenue AI tools without regulatory clearance or clinical validation will not match this profile. Check sizes at a firm of this type typically span single-digit to low-double-digit millions, with flexibility on structure including equity, convertible, or quasi-equity. Founders should not expect deep healthcare domain coaching or clinical introductions as the core value-add; this is a capital partner. The best entry path is via a Swiss or European investment banker, a wealth advisor with relationships into the firm, or a warm introduction through an existing portfolio CEO. Cold outreach via LinkedIn to the firm’s investment team is acceptable but should be paired with a tight commercial summary, audited financials or near-equivalent, and a specific use of proceeds.